orphan drugs

基本解釋

EU-wide harmonisation in the context of accessibility processes and price policies will reduce delays in the availability of orphan drugs.
全歐盟范圍內(nèi)統(tǒng)一的無障礙進程和價格政策將減少延誤可用性孤兒藥。
The European orphan diseases market grapples with numerous challenges. Of these, the most serious are the lack of awareness, poor diagnosis and limited accessibility of orphan drugs.
歐洲孤兒疾病市場存在許多問題。其中，最嚴重的是缺乏認識，不良的診斷和有限利用孤兒藥物。
EU healthcare ministers should encourage frequent discussions with patients, patient support groups and industry representatives to ensure a transparent and rapid approval process for orphan drugs.
歐盟衛(wèi)生部長會議鼓勵要經(jīng)常性的與患者，患者支持團體和業(yè)界代表進行溝通，以確保透明和快速審批程序孤兒藥物。

But before 1983, there were just 38 orphan drugs approved for use in the United States.
FORBES: The Lifesaving Promise Of The Pharmaceutical Drug Pipeline
Insurers may want to avoid negative publicity and will pay for orphan drugs, assuming patient populations remain small.
FORBES: Connect
New orphan drugs are just one of the reasons that individuals with hard-to-treat diseases have reason to hope.
FORBES: The Lifesaving Promise Of The Pharmaceutical Drug Pipeline

罕用藥
It is very necessary for the government to intervene to improve the accessibility of orphan drugs.2.
因此,在市場經(jīng)濟條件下,要促進患者罕用藥的可及性,政府干預必不可少。